AU4373499A - Use of drug-loaded nanoparticles for the treatment of cancers - Google Patents

Use of drug-loaded nanoparticles for the treatment of cancers

Info

Publication number
AU4373499A
AU4373499A AU43734/99A AU4373499A AU4373499A AU 4373499 A AU4373499 A AU 4373499A AU 43734/99 A AU43734/99 A AU 43734/99A AU 4373499 A AU4373499 A AU 4373499A AU 4373499 A AU4373499 A AU 4373499A
Authority
AU
Australia
Prior art keywords
cancers
drug
treatment
loaded nanoparticles
nanoparticles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43734/99A
Inventor
Svetlana Gelperina
Jorg Kreuter
Bernhard A. Sabel
Ulrike Schroder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medinova Medical Consulting GmbH
Original Assignee
Medinova Medical Consulting GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medinova Medical Consulting GmbH filed Critical Medinova Medical Consulting GmbH
Publication of AU4373499A publication Critical patent/AU4373499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AU43734/99A 1999-06-02 1999-06-02 Use of drug-loaded nanoparticles for the treatment of cancers Abandoned AU4373499A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1999/003838 WO2000074658A1 (en) 1999-06-02 1999-06-02 Use of drug-loaded nanoparticles for the treatment of cancers

Publications (1)

Publication Number Publication Date
AU4373499A true AU4373499A (en) 2000-12-28

Family

ID=8167319

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43734/99A Abandoned AU4373499A (en) 1999-06-02 1999-06-02 Use of drug-loaded nanoparticles for the treatment of cancers

Country Status (4)

Country Link
EP (1) EP1100475A1 (en)
JP (1) JP2003501379A (en)
AU (1) AU4373499A (en)
WO (1) WO2000074658A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69728179T2 (en) 1997-06-13 2004-11-25 Nanodel Technologies Gmbh SYSTEM FOR TARGETED ACTIVE SUBSTANCE, METHOD FOR THE PRODUCTION AND USE THEREOF
US7153525B1 (en) 2000-03-22 2006-12-26 The University Of Kentucky Research Foundation Microemulsions as precursors to solid nanoparticles
AUPR011700A0 (en) 2000-09-14 2000-10-05 Austin Research Institute, The Composition comprising immunogenic virus sized particles (VSP)
DE10121982B4 (en) * 2001-05-05 2008-01-24 Lts Lohmann Therapie-Systeme Ag Nanoparticles of protein with coupled apolipoprotein E to overcome the blood-brain barrier and process for their preparation
US6878693B2 (en) 2001-09-28 2005-04-12 Solubest Ltd. Hydrophilic complexes of lipophilic materials and an apparatus and method for their production
WO2003028700A2 (en) * 2001-09-28 2003-04-10 Solubest Ltd. Water soluble nanoparticles of hydrophilic and hydrophobic active materials
US7763663B2 (en) 2001-12-19 2010-07-27 University Of Massachusetts Polysaccharide-containing block copolymer particles and uses thereof
DK1526840T3 (en) * 2002-07-29 2008-11-03 Nanodel Technologies Gmbh Nanoparticles for DNA administration to a target organ
US20060228420A1 (en) * 2005-03-15 2006-10-12 Queen Mary & Westfield College Pharmaceutical compositions comprising microparticles for delivery into neurons
JPWO2007037474A1 (en) 2005-09-30 2009-04-16 Ｔｔｉ・エルビュー株式会社 Electrode structure for iontophoresis for drug administration encapsulated in nanoparticles and iontophoresis device using the same
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
DE102005062440B4 (en) * 2005-12-27 2011-02-24 Lts Lohmann Therapie-Systeme Ag Protein-based carrier system for the resistance of tumor cells
WO2007079193A2 (en) 2005-12-30 2007-07-12 Tti Ellebeau, Inc. Iontophoretic systems, devices, and methods of delivery of active agents to biological interface
JPWO2008044705A1 (en) 2006-10-10 2010-02-12 Ｔｔｉ・エルビュー株式会社 Denture iontophoresis device
JP5201763B2 (en) * 2007-02-28 2013-06-05 昇一 城武 Method for producing mixed fine particle capsules comprising particles having different average particle sizes
EP1985286A1 (en) * 2007-04-24 2008-10-29 Biocompatibles UK Limited Microspheres for treatment of brain tumours
WO2010040173A1 (en) * 2008-10-08 2010-04-15 Commonwealth Scientific And Industrial Research Organisation A method of delivering functional agents across the blood-brain barrier
GB201209517D0 (en) * 2012-05-29 2012-07-11 Univ Birmingham Nanoparticles
CN103623424B (en) * 2012-08-24 2016-08-03 复旦大学 A kind of brain targeting gene based on polymethacrylates passs release system
CN117731591A (en) 2016-11-21 2024-03-22 艾里奥治疗公司 Transdermal delivery of large agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2634397B2 (en) * 1986-12-31 1991-04-19 Centre Nat Rech Scient PROCESS FOR THE PREPARATION OF DISPERSIBLE COLLOIDAL SYSTEMS OF A PROTEIN IN THE FORM OF NANOPARTICLES
ES2188652T3 (en) * 1994-02-28 2003-07-01 Nanopharm Ag SYSTEM OF ADDRESSING PHARMACOS, METHODS OF MANUFACTURING AND USE OF THE SAME.
DE69728179T2 (en) * 1997-06-13 2004-11-25 Nanodel Technologies Gmbh SYSTEM FOR TARGETED ACTIVE SUBSTANCE, METHOD FOR THE PRODUCTION AND USE THEREOF
DE19745950A1 (en) * 1997-10-17 1999-04-22 Dds Drug Delivery Service Ges Drug carrier particle for site specific drug delivery, especially to CNS

Also Published As

Publication number Publication date
WO2000074658A1 (en) 2000-12-14
JP2003501379A (en) 2003-01-14
EP1100475A1 (en) 2001-05-23

Similar Documents

Publication Publication Date Title
AU4373499A (en) Use of drug-loaded nanoparticles for the treatment of cancers
PL354540A1 (en) Drugs for the treatment of malignant tumours
IL152754A0 (en) Quinazoline derivatives for the treatment of tumours
PL370029A1 (en) 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
EP1176964B8 (en) Uses of et743 for treating cancer
AU2002226030A1 (en) Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
AU5497000A (en) Non-malignant disease treatment with ras antagonists
AU2002217866A1 (en) Geldanamycin derivatives useful for the treatment of cancer
AU6062900A (en) Substituted indole compounds and their use for the treatment of cancer
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
AU1916601A (en) Oncolytic combinations for the treatment of cancer
AU4770800A (en) Body treatment product
AU1916501A (en) Oncolytic combinations for the treatment of cancer
AU2001214116A1 (en) Novel paclitaxel derivatives for the treatment of cancer
AU7636800A (en) Improved ricin-like toxins for treatment of cancer
AU1917101A (en) Oncolytic combinations for the treatment of cancer
AU1595001A (en) Oncolytic combinations for the treatment of cancer
AUPQ367699A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer
AU1595101A (en) Oncolytic combinations for the treatment of cancer
AU1618901A (en) Treatment of rosacea

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase